<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00510744</url>
  </required_header>
  <id_info>
    <org_study_id>PRO07070305</org_study_id>
    <nct_id>NCT00510744</nct_id>
  </id_info>
  <brief_title>Pancreatic Enzymes to Restore Digestive Function in Malnourished Gastric Bypass Patients</brief_title>
  <official_title>Pancreatic Enzymes to Restore Digestive Function in Malnourished Gastric Bypass Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Solvay Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypothesis: Bypass of the upper GI tract with bariatric surgery results in suppression of
      pancreatic function resulting in maldigestion and further malabsorption. In this study we
      will measure pancreatic secretion in previously obese gastric bypass patients with excessive
      weight loss. If malabsorption is associated with diminished pancreatic secretion, we will
      test over a 3 month period whether supplementation with enzyme supplements prevent further
      weight loss.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obesity has reached epidemic proportions in the USA and Europe, and is increasing world-wide.
      Morbid obesity (BMI&gt;40kg/m2) is usually resistant to medical and dietary therapy while
      surgical treatment results in a permanent loss of most of the excess weight. The most popular
      technique today is the Roux-en-Y gastric bypass procedure which results in a weight loss of
      approximately 95 lbs per year or a 2/3 loss of the excess weight in 2 years (7-9). Weight
      loss occurs for 2 reasons: first the volume of the stomach is reduced, and second, the
      duodenum and first part of the jejunum is bypassed resulting in malabsorption. Although most
      patients tolerate the procedure well with a leveling off of weight loss close to the ideal
      body weight, a subpopulation of patients continue to lose weight, becoming progressively more
      malnourished, necessitating reversal of the surgery. To date, no studies have investigated
      what happens to pancreatic function in obese patients following bypass surgery, but from an
      understanding of the physiology of pancreatic stimulation, it is likely that the pancreas
      atrophies because the intestinal phase of pancreatic stimulation is bypassed and the
      inhibitory ileal brake is perpetually stimulated. In the following study we plan to
      investigate whether patients with excessive weight loss after bypass surgery develop
      malabsorption not only due to bypass of the upper GI tract but also because of impaired
      pancreatic enzyme secretion resulting from chronic activation of the ileal brake mechanism.
      Up to 20 post-bariatric surgery (Roux-en-Y) patients with excessive and continued weight loss
      will be screened for fat absorption and loss of pancreatic secretion. Those with loss of &gt;20%
      fat absorption will then be treated at home with pancreatic enzyme supplements for a 3 month
      period to assess weight stabilization or gain. After 3 months, fat absorption and the
      pancreatic stimulation test will be repeated while patients are on enzyme supplementation to
      determine whether fat digestion and absorption has improved from baseline.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2007</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fat Absorption</measure>
    <time_frame>3 months</time_frame>
    <description>72 hour fat absorption study</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">5</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>pancreatic enzyme supplementation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3 month supplementation in those gastric bypass patients shown to have a fat absorption less than 80%</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>pancreatic enzyme supplement</intervention_name>
    <description>4 caps with meals, 2 with snacks</description>
    <arm_group_label>pancreatic enzyme supplementation</arm_group_label>
    <other_name>Creon</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male or female adults &gt;18yrs

          2. h/o Roux-en-Y gastric bypass procedure

          3. Pre-surgery BMI &gt;40Kg/m2

          4. Weight loss of &gt;30%, or 100lbs in 1st year following bypass surgery

          5. Able to consume normal requirement levels of food. This will be determined from
             history (see above) and confirmed during the 72h food-balance study in the GCRC.

        Exclusion Criteria:

          1. Chronic pancreatic disease as evidenced by history, pancreatic imaging (CT or MRP
             scanning or ERCP) or alcohol abuse (&gt;3 units of alcohol/day) as documented by family
             or care givers

          2. h/o intestinal resection other than gastric bypass

          3. Unstable cardio-respiratory status (BP diastolic &gt;100mmHg, systolic &gt;200 or &lt;80 mmHg),
             ambient pO2 &lt;90%

          4. Presence of chronic inflammatory bowel or chronic small intestinal mucosal disease
             confirmed by radiology and biopsy.

          5. Current history of feeding disorder, such as bulimia nervosa. This will be excluded by
             the interview and attestation of spouses, close relatives, or home companions

          6. Pregnant women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephen J O'Keefe, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Pittsburgh GCRC</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 1, 2007</study_first_submitted>
  <study_first_submitted_qc>August 1, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 2, 2007</study_first_posted>
  <results_first_submitted>April 26, 2016</results_first_submitted>
  <results_first_submitted_qc>April 26, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 2, 2016</results_first_posted>
  <last_update_submitted>April 26, 2016</last_update_submitted>
  <last_update_submitted_qc>April 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 2, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>Stephen O'Keefe</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>obesity, bariatric surgery, pancreatic secretion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Malnutrition</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>with publication</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Pancreatic Enzyme Supplementation</title>
          <description>3 month supplementation in those gastric bypass patients shown to have a fat absorption less than 80%
pancreatic enzyme supplement: 4 caps with meals, 2 with snacks</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Pancreatic Enzyme Supplementation</title>
          <description>3 month supplementation in those gastric bypass patients shown to have a fat absorption less than 80%
pancreatic enzyme supplement: 4 caps with meals, 2 with snacks</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="5"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49" lower_limit="22" upper_limit="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Fat Absorption</title>
        <description>72 hour fat absorption study</description>
        <time_frame>3 months</time_frame>
        <population>each patients as their own control, baseline fat absorption vs post 3 month enzyme supplementation fat absorption</population>
        <group_list>
          <group group_id="O1">
            <title>Pancreatic Enzyme Supplementation</title>
            <description>3 month supplementation in those gastric bypass patients shown to have a fat absorption less than 80%
The ability of pancreatic enzyme supplement: 4 caps with meals, 2 with snacks to improve fat absorption</description>
          </group>
        </group_list>
        <measure>
          <title>Fat Absorption</title>
          <description>72 hour fat absorption study</description>
          <population>each patients as their own control, baseline fat absorption vs post 3 month enzyme supplementation fat absorption</population>
          <units>g/d</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.6" spread="13.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>paired changes in fat absorption assessed by parametric (t test) or non-parametric tests (Mann-Whitney)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.2</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>24</dispersion_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Pancreatic Enzyme Supplementation</title>
          <description>3 month supplementation in those gastric bypass patients shown to have a fat absorption less than 80%
pancreatic enzyme supplement: 4 caps with meals, 2 with snacks</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Stephen O'Keefe</name_or_title>
      <organization>University of Pittsburgh</organization>
      <phone>412 648 7217</phone>
      <email>sjokeefe@pitt.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

